Expert Interview
Discussing how payor's are strategizing reimbursement for GLP-1 drugs for the prevention of heart disease based on cardiovascular benefits shown in the SELECT trial.
Ticker(s): NVOInstitution: Cardiac Imaging and Research Consultants
- Sr. Director Clinical Drug Management and Pharmacy Benefits Programs
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
